MAR vs V: Which Is the Better Buy?

Side-by-side comparison of Marriott International, Inc. and Visa Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-07.
Marriott International, Inc. ยท Consumer Cyclical
$359.06
-45.0% upside to fair value
Grade D
VS
Visa Inc. ยท Financial Services
$304.36
+45.0% upside to fair value
High Conviction Grade A-
QuantHub Verdict
V has more upside to fair value (+45.0%). V trades at a lower forward P/E (23.7x). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric MAR V
Current Price $359.06 $304.36
Fair Value Estimate $197.48 $441.32
Upside to Fair Value -45.0% +45.0%
Market Cap $95.2B $586.8B
Forward P/E 37.7x 23.7x
EV / EBITDA 29.5x 22.3x
Price / Sales 4.4x 14.2x
Price / FCF 29.3x 25.6x
Revenue Growth YoY -71.1% +11.3%
Gross Margin 6.0% 81.08%
Operating Margin 19.6% 59.18%
Return on Equity -78.5% 54.22%
Dividend Yield 0% 0.83%
FCF Yield 3.41% 3.91%
Analyst Consensus Hold Strong Buy
Investment Thesis
MAR โ€” Marriott International, Inc.
Marriott International operates a global fee-driven, asset-light hotel business with a portfolio of over 30 brands and a strong competitive position in the travel lodging industry. The company benefits from a durable competitive moat supported by its brand strength, extensive network, and recurring franchise and management fees. However, recent financials show significant headwinds with a 71.1% yโ€ฆ
V โ€” Visa Inc.
Visa is the world's dominant payment network with $40B in net revenue (FY2025), 50%+ net margins, and a capital-light toll-booth model processing $14.2T in annual payment volume across 257.5B transactions. The business compounds at 10-12% revenue CAGR with operating leverage pushing EPS growth to 12-15% over a cycle, funded by $21.6B in annual free cash flow against only $1.5B in capex. At 28.0x โ€ฆ
Accumulation Zones
Metric MAR V
Zone Low $148.11 $330.99
Zone High $167.86 $375.12
In Buy Zone? No Yes
โ† MAR Research    V Research โ†’    All Research